Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT06946589

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Jordan Leitch (from the registry)
Registry
  • NCT NCT06946589
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06946589. Randomized; double masking; primary purpose treatment. Start 2025-08-01 (anticipated); primary completion 2026-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cardiac Changes After Effective Dose Carbetocin for Elective Caesarian Section
Condition
Cardiac Ischemia
Condition
Cesarian Section
Intervention (Drug)
Carbetocin
Lead sponsor
Jordan Leitch (class: other)

Record details

Record id
cardio:ct-nct06946589
Content hash
8b97ad956274849d56c7e71aa77b2f3f383f6063e95297067adb995921dc95a7